NIH Nominee Says Americans Deserve ‘Return On Investment’ Via Affordable Meds, But Offers No Implementation Plan

 
• By Sarah Karlin-Smith

Monica Bertagnolli angered Senators on both sides of the pricing debate during her confirmation hearing when said she would execute a plan to ensure the benefits of NIH research are affordable and available to all Americans but couldn’t offer any specifics on how she would achieve it.

Marta Betagnolli at her Senate HELP nomination hearing
Monica Bertagnolli testified 18 October on her nomination to lead the NIH • Source: Senate HELP Committee

More from Pricing Debate

More from Market Access